Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Bariatric surgery prior to joint replacement improves outcomes in obese patients

Obesity is not only a risk factor for developing knee and hip arthritis. It is also linked to less favorable outcomes after joint replacement surgery.

30 Mar 2015

Hip replacement procedure alleviates pain, improves function in young JIA patients

Hip replacement is often performed in patients with juvenile arthritis when their joints have been severely damaged by the disease.

25 Mar 2015

Previous joint pain, diabetes and overall health status may predict arthritis pain

Diabetes and previous joint pain, along with a patient's overall physical health status, may predict arthritis pain with nearly 100 percent accuracy, in new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

24 Mar 2015

Implementation of video-based decision aids influences care decisions in urology

After Group Health Cooperative implemented video-based decision aids for men with two common prostate conditions, rates of elective surgery for benign prostatic hyperplasia (BPH) and rates of active treatment for localized prostate cancer declined over six months.

24 Mar 2015

Stem cell treatment for osteoarthritis of the knee may help rebuild lost cartilage

Recent studies employing adult stem cells obtained from bone marrow and fat have been used in patients suffering from osteoarthritis of the knee. Results have indicated not only symptomatic improvement but also suggest that cartilage healing and regeneration may be taking place.

23 Mar 2015

Discovery raises potential of blood test that can help diagnose osteoarthritis, rheumatoid

The first blood test for osteoarthritis could soon be developed, thanks to research by the University of Warwick.

20 Mar 2015

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.

18 Mar 2015

Ember Therapeutics, Mariel Therapeutics sign definitive merger agreement

Ember Therapeutics, Inc., a Boston-based biotechnology company dedicated to the discovery and development of novel obesity and diabetic related therapies, and Mariel Therapeutics, a privately held, New York-based biotechnology company developing targeted therapies for osteoarthritis and kidney fibrosis using Bone Morphogenetic Protein (BMP)-7, jointly announce today that they have entered into a definitive agreement to merge the two companies.

12 Mar 2015

Study shows strong link between adolescent obesity and high blood pressure

A recent study published in the American Journal of Hypertension has found that body mass index (BMI) in healthy adolescents has a statistically significant association with both systolic blood pressures (SBP) and diastolic blood pressures (DBP), and highlights the significance of the global trend of rapidly increasing adolescent obesity.

4 Mar 2015

Scientists produce cartilage from embryonic stem cells

Scientists have succeeded in producing cartilage formed from embryonic stem cells that could in future be used to treat the painful joint condition osteoarthritis.

3 Mar 2015

Study finds that BMI in healthy adolescents has significant association with blood pressures

3 Mar 2015

NYU Langone becomes first center in New York City to start outpatient hip replacement program

NYU Langone Medical Center in January became the first academic medical center in the New York City area to initiate an outpatient hip replacement program after successfully discharging a patient the same day of surgery.

3 Mar 2015

Insurance coverage expansion in Massachusetts increases knee, hip replacement procedures by 4.7%

Researchers at Boston Medical Center have found that the expansion of insurance coverage in Massachusetts increased the number of elective knee and hip replacement procedures by 4.7 percent, with greater increases among black and Hispanic patients.

27 Feb 2015

New, first-of-its-kind app helps patients with chronic pain track opioid use

A new, first-of-its-kind app has launched to help patients suffering from chronic pain track their opioid use and measure pain levels to assist with the safe use of opioids.

25 Feb 2015

Indiana University study reveals connection between mussels and muscles

An Indiana University study has revealed that there may be a greater connection between mussels and muscles than previously thought.

25 Feb 2015

New research finds that synthetic flame retardants can cause metabolic and liver problems

Chemicals used as synthetic flame retardants that are found in common household items such as couches, carpet padding, and electronics have been found to cause metabolic and liver problems that can lead to insulin resistance, which is a major cause of obesity, according to new research from the University of New Hampshire.

20 Feb 2015

High-impact exercise improves patellar cartilage quality of postmenopausal women at risk of osteoporosis

Progressive high-impact training improved the patellar cartilage quality of the postmenopausal women who may be at risk of osteoporosis (bone loss) as well as at risk of osteoarthritis.

18 Feb 2015

TINA.org objects to proposed class-action settlement regarding Wellesse glucosamine supplement

Continuing its efforts to fight for settlements that are fair to consumers and mandate real changes in deceptive marketing, advocacy group truthinadvertising.org (TINA.org) has filed an objection in a proposed class-action settlement involving the brand-name glucosamine supplement, Wellesse®. Sold at retailers nationwide, the supplement is advertised as a joint pain remedy to ease pain and even rebuild cartilage.

12 Feb 2015

DePuy Synthes announces acquisition of Olive Medical

Today DePuy Synthes Companies announced that it has acquired Olive Medical Corporation, a Utah-based privately held provider of high definition (HD) visualization systems for minimally invasive surgery (MIS). Financial terms of the transaction were not disclosed.

10 Feb 2015

ANI Pharmaceuticals launches Etodolac 300mg oral capsules

ANI Pharmaceuticals, Inc. today announced the launch of Etodolac 300mg oral capsules, indicated for use in the management of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and acute pain.

30 Jan 2015

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Bariatric surgery prior to joint replacement improves outcomes in obese patients

Hip replacement procedure alleviates pain, improves function in young JIA patients

Previous joint pain, diabetes and overall health status may predict arthritis pain

Implementation of video-based decision aids influences care decisions in urology

Stem cell treatment for osteoarthritis of the knee may help rebuild lost cartilage

Discovery raises potential of blood test that can help diagnose osteoarthritis, rheumatoid

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Ember Therapeutics, Mariel Therapeutics sign definitive merger agreement

Study shows strong link between adolescent obesity and high blood pressure

Scientists produce cartilage from embryonic stem cells

Study finds that BMI in healthy adolescents has significant association with blood pressures

NYU Langone becomes first center in New York City to start outpatient hip replacement program

Insurance coverage expansion in Massachusetts increases knee, hip replacement procedures by 4.7%

New, first-of-its-kind app helps patients with chronic pain track opioid use

Indiana University study reveals connection between mussels and muscles

New research finds that synthetic flame retardants can cause metabolic and liver problems

High-impact exercise improves patellar cartilage quality of postmenopausal women at risk of osteoporosis

TINA.org objects to proposed class-action settlement regarding Wellesse glucosamine supplement

DePuy Synthes announces acquisition of Olive Medical

ANI Pharmaceuticals launches Etodolac 300mg oral capsules

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in